Association of FGFR2 rs2981582 polymorphism and breast cancer susceptibility: An updated systematic review and meta-analysis

[1]  K. Langeswaran,et al.  Association of RAMP-1 gene polymorphisms and risk of migraine: Systemic review and meta-analysis , 2023, Human Gene.

[2]  A. Jemal,et al.  Breast Cancer Statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[3]  J. Bauman,et al.  c-Met Signaling as a Therapeutic Target in Head and Neck Cancer , 2022, Cancer journal.

[4]  I. Soerjomataram,et al.  Current and future burden of breast cancer: Global statistics for 2020 and 2040 , 2022, Breast.

[5]  Sindhu Varghese,et al.  Association of VEGF polymorphisms and breast cancer susceptibility: Systemic review and meta-analysis , 2021 .

[6]  Sameer Ahmad Guru.  "Association of Fibroblast Growth Factor Receptor Gene (FGFR2) Polymorphism (rs2981582) and its Expression with Breast Cancer" , 2021, Biomedical Journal of Scientific & Technical Research.

[7]  S. Kumar,et al.  LDLR, MTHFR and KLOTHO gene polymorphisms as an early predictor in the risk of coronary artery disease: A meta-analysis , 2021 .

[8]  Gayathri Natarajan,et al.  Association of interleukin1β, interleukin1 receptor antagonist, interleukin 6 and angiotensin II receptor type I gene polymorphisms with end stage renal disease: A meta-analysis , 2020 .

[9]  S. Kumar,et al.  Association of Interleukin 6 and insulin resistance gene polymorphism with polycystic ovarian syndrome: A meta-analysis , 2020 .

[10]  R. Jamal,et al.  Association between MIR499A rs3746444 polymorphism and breast cancer susceptibility: a meta-analysis , 2020, Scientific Reports.

[11]  S. Kumar,et al.  Association between genetic variants of NOS3, TGF-β and susceptibility of diabetic nephropathy: A meta-analysis , 2019, Meta Gene.

[12]  Juan Zhao,et al.  Correlation of FGFR2 rs2981582 polymorphisms with susceptibility to breast cancer: a case-control study in a Chinese population , 2019, The Journal of international medical research.

[13]  Shiek S. S. J. Ahmed,et al.  Prevalence of human papilloma virus with risk of cervical cancer among south Indian women: A genotypic study with meta-analysis and molecular dynamics of HPV E6 oncoprotein. , 2018, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[14]  Yongsheng Wang,et al.  Association of FGFR2 and PI3KCA genetic variants with the risk of breast cancer in a Chinese population , 2018, Cancer management and research.

[15]  V. Ramakrishnan,et al.  Association Between NOS1 Gene Polymorphisms and Schizophrenia in Asian and Caucasian Populations: A Meta-Analysis , 2017, NeuroMolecular Medicine.

[16]  Le Lu,et al.  Association between FGFR2 (rs2981582, rs2420946 and rs2981578) polymorphism and breast cancer susceptibility: a meta-analysis , 2016, Oncotarget.

[17]  Q. Bashir,et al.  Genetic variants in FGFR2 and TNRC9 genes are associated with breast cancer risk in Pakistani women. , 2016, Molecular medicine reports.

[18]  Amir Mehrgou,et al.  The importance of BRCA1 and BRCA2 genes mutations in breast cancer development , 2016, Medical journal of the Islamic Republic of Iran.

[19]  N. Aitkhozhina,et al.  Lack of Association between Polymorphisms in rs2981582, rs2420946, rs17102287, rs1219648, rs2981578, and rs17542768 Sites of FGFR2 Gene with Breast Cancer in the Population of Kazakhstan , 2015 .

[20]  L. Kang,et al.  FGFR2 gene polymorphisms are associated with breast cancer risk in the Han Chinese population. , 2015, American journal of cancer research.

[21]  W. Jia,et al.  Association of physical activity and polymorphisms in FGFR2 and DNA methylation related genes with breast cancer risk. , 2014, Cancer epidemiology.

[22]  S. Husain,et al.  A Study on Genetic Variants of Fibroblast Growth Factor Receptor 2 (FGFR2) and the Risk of Breast Cancer from North India , 2014, PloS one.

[23]  Kathy B. Baumgartner,et al.  Associations with growth factor genes (FGF1, FGF2, PDGFB, FGFR2, NRG2, EGF, ERBB2) with breast cancer risk and survival: the Breast Cancer Health Disparities Study , 2013, Breast Cancer Research and Treatment.

[24]  Elad Ziv,et al.  Association between rs2981582 polymorphism in the FGFR2 gene and the risk of breast cancer in Mexican women. , 2013, Archives of medical research.

[25]  H. Luan,et al.  Three novel functional polymorphisms in the promoter of FGFR2 gene and breast cancer risk: a HuGE review and meta-analysis , 2012, Breast Cancer Research and Treatment.

[26]  P. Ang,et al.  Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population , 2012, Breast Cancer Research and Treatment.

[27]  J. Carlson,et al.  Genetic predisposition, parity, age at first childbirth and risk for breast cancer , 2012, BMC Research Notes.

[28]  He-guang Huang,et al.  Polymorphisms in second intron of the FGFR2 gene are associated with the risk of early-onset breast cancer in Chinese Han women. , 2012, The Tohoku journal of experimental medicine.

[29]  Hongbing Shen,et al.  Breast cancer risk assessment with five independent genetic variants and two risk factors in Chinese women , 2012, Breast Cancer Research.

[30]  Ahmedin Jemal,et al.  Breast cancer statistics, 2011 , 2011, CA: a cancer journal for clinicians.

[31]  S. Ambs,et al.  Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale. , 2011, Carcinogenesis.

[32]  R. Wolff,et al.  Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States , 2011, Breast Cancer Research and Treatment.

[33]  A. Thompson,et al.  FGFR2 protein expression in breast cancer: nuclear localisation and correlation with patient genotype , 2011, BMC Research Notes.

[34]  E. Imyanitov,et al.  Distribution of FGFR2, TNRC9, MAP3K1, LSP1, and 8q24 alleles in genetically enriched breast cancer patients versus elderly tumor-free women. , 2010, Cancer genetics and cytogenetics.

[35]  N. Turner,et al.  Fibroblast growth factor signalling: from development to cancer , 2010, Nature Reviews Cancer.

[36]  K. Czene,et al.  Birth weight, breast cancer susceptibility loci, and breast cancer risk , 2010, Cancer Causes & Control.

[37]  N. Miller,et al.  Low penetrance breast cancer predisposition SNPs are site specific , 2009, Breast Cancer Research and Treatment.

[38]  Y. Aulchenko,et al.  Association of FGFR2 gene polymorphisms with the risk of breast cancer in population of West Siberia , 2009, European Journal of Human Genetics.

[39]  Hongbing Shen,et al.  Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women. , 2008, Carcinogenesis.

[40]  Stephen B. Gruber,et al.  FGFR2 Is a Breast Cancer Susceptibility Gene in Jewish and Arab Israeli Populations , 2008, Cancer Epidemiology Biomarkers & Prevention.

[41]  Dieter Niederacher,et al.  Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. , 2008, American journal of human genetics.

[42]  W. Willett,et al.  A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer , 2007, Nature Genetics.

[43]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[44]  P. Carmeliet,et al.  Angiogenesis in cancer and other diseases , 2000, Nature.

[45]  S. Neuhausen.  Ethnic differences in cancer risk resulting from genetic variation , 1999, Cancer.

[46]  M. Grendár,et al.  Association of single nucleotide polymorphisms in FGF-RAS/MAP signalling cascade with breast cancer susceptibility. , 2017, General physiology and biophysics.

[47]  A. Jemal,et al.  Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[48]  Gladys Ibanez,et al.  Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population , 2012, Breast Cancer Research and Treatment.

[49]  Fan Chen,et al.  Erratum to: Genetic variants of fibroblast growth factor receptor 2 (FGFR2) are associated with breast cancer risk in Chinese women of the Han nationality , 2011, Immunogenetics.